BioCentury | Apr 20, 2018
Financial News

Inventiva raises €35.5M in private placement

Inventiva S.A. (Euronext:IVA) raised €35.5 million ($43.8 million) on April 13 in a private placement through the sale of 5.6 million shares at €6.37. Investors included BVF Partners, Novo Holdings A/S and Sofinnova Crossover I...
BioCentury | Apr 13, 2018
Financial News

Inventiva raises €35.5M in private placement

Inventiva S.A. (Euronext:IVA) raised €35.5 million ($43.8 million) in a private placement through the sale of 5.6 million shares at €6.37. Investors included BVF Partners, Novo Holdings A/S and Sofinnova Crossover I fund. The price...
BioCentury | Feb 17, 2017
Financial News

Inventiva completes IPO

Cancer, fibrosis and autoimmune company Inventiva S.A. (Euronext:IVA) raised €48 million ($51.2 million) through the sale of 5.7 million shares at €8.50 in an IPO underwritten by Société Générale and KBC Securities on Feb. 14....
BioCentury | Feb 14, 2017
Financial News

Inventiva raises EUR 48M in IPO

...through the sale of 5.7 million shares at EUR 8.50 in an IPO underwritten by Societe Generale...
BioCentury | Feb 10, 2017
Financial News

Lysogene completes IPO

Gene therapy company Lysogene S.A. (Euronext:LYS) raised €22.6 million ($24.3 million) through the sale of 3.3 million shares at €6.80 in an IPO underwritten by Société Générale and Gilbert Dupont on Feb. 7. Lysogene said...
BioCentury | Feb 8, 2017
Financial News

Lysogene raises EUR 22.6M in IPO

Lysogene S.A. (Euronext:LYS) raised EUR 22.6 million ($24.3 million) through the sale of 3.3 million shares at EUR 6.80 in an IPO underwritten by Societe General and Gilbert Dupont. The offering values the company at...
BioCentury | Apr 25, 2016
Financial News

GeNeuro completes IPO

...Shares: 2.5 million Price: EUR13 Shares after offering: 14.7 million Underwriters: Bryan, Garnier & Co.; Societe Generale...
BioCentury | Aug 3, 2015
Financial News

Poxel completes private placement

...million) Shares: 1.8 million Price: EUR11.35 Shares after offering: 19.4 million Placement Agents: Guggenheim Securities; Societe Generale...
BioCentury | Apr 6, 2015
Financial News

UCB completes bond

...Bond Raised: EUR350 million ($379.1 million) Investor: Institutional investors Underwriters: BNP Paribas; BofA Merrill Lynch; Societe Generale...
BioCentury | Feb 9, 2015
Financial News

Poxel completes IPO

...million) Shares: 3.7 million Price: EUR6.66 Shares after offering: 17.3 million Underwriters: Oddo et Cie; Societe Generale...
Items per page:
1 - 10 of 109
BioCentury | Apr 20, 2018
Financial News

Inventiva raises €35.5M in private placement

Inventiva S.A. (Euronext:IVA) raised €35.5 million ($43.8 million) on April 13 in a private placement through the sale of 5.6 million shares at €6.37. Investors included BVF Partners, Novo Holdings A/S and Sofinnova Crossover I...
BioCentury | Apr 13, 2018
Financial News

Inventiva raises €35.5M in private placement

Inventiva S.A. (Euronext:IVA) raised €35.5 million ($43.8 million) in a private placement through the sale of 5.6 million shares at €6.37. Investors included BVF Partners, Novo Holdings A/S and Sofinnova Crossover I fund. The price...
BioCentury | Feb 17, 2017
Financial News

Inventiva completes IPO

Cancer, fibrosis and autoimmune company Inventiva S.A. (Euronext:IVA) raised €48 million ($51.2 million) through the sale of 5.7 million shares at €8.50 in an IPO underwritten by Société Générale and KBC Securities on Feb. 14....
BioCentury | Feb 14, 2017
Financial News

Inventiva raises EUR 48M in IPO

...through the sale of 5.7 million shares at EUR 8.50 in an IPO underwritten by Societe Generale...
BioCentury | Feb 10, 2017
Financial News

Lysogene completes IPO

Gene therapy company Lysogene S.A. (Euronext:LYS) raised €22.6 million ($24.3 million) through the sale of 3.3 million shares at €6.80 in an IPO underwritten by Société Générale and Gilbert Dupont on Feb. 7. Lysogene said...
BioCentury | Feb 8, 2017
Financial News

Lysogene raises EUR 22.6M in IPO

Lysogene S.A. (Euronext:LYS) raised EUR 22.6 million ($24.3 million) through the sale of 3.3 million shares at EUR 6.80 in an IPO underwritten by Societe General and Gilbert Dupont. The offering values the company at...
BioCentury | Apr 25, 2016
Financial News

GeNeuro completes IPO

...Shares: 2.5 million Price: EUR13 Shares after offering: 14.7 million Underwriters: Bryan, Garnier & Co.; Societe Generale...
BioCentury | Aug 3, 2015
Financial News

Poxel completes private placement

...million) Shares: 1.8 million Price: EUR11.35 Shares after offering: 19.4 million Placement Agents: Guggenheim Securities; Societe Generale...
BioCentury | Apr 6, 2015
Financial News

UCB completes bond

...Bond Raised: EUR350 million ($379.1 million) Investor: Institutional investors Underwriters: BNP Paribas; BofA Merrill Lynch; Societe Generale...
BioCentury | Feb 9, 2015
Financial News

Poxel completes IPO

...million) Shares: 3.7 million Price: EUR6.66 Shares after offering: 17.3 million Underwriters: Oddo et Cie; Societe Generale...
Items per page:
1 - 10 of 109